UNDERSTANDING TRANSGENDER ISSUES

UNDERSTANDING
TRANSGENDER ISSUES

Resources by Topic

Experimentation

Books

Videos

Gender Dysphoria in Children: A Cry for Help Not Hormones

The Boyce of Reason

Commonsense Care

Dysphoric

Medical Harms from the Treatment of Child and Adolescent Gender Dysphoria

NHS child gender clinic: Staff welfare concerns ‘shut down’ – BBC Newsnight

The Rise of Transgender Medicine

Detransition Conference and medical ethics in the age of gender identity

ROGD Webinar

Trans Mission

Trans Train

Utah House Judiciary Committee Hearing Highlights on HB 399

Michelle Cretella

Organizations

Parent Support Organizations

Professional Organizations

Research

The Dutch Protocol for Juvenile Transsexuals: Origins and Evidence

It has been a quarter of a century since Dutch clinicians proposed puberty suppression as an intervention for “juvenile transsexuals,” which became the international standard for treating gender dysphoria. This paper reviews the history of this intervention and scrutinizes the evidence adduced to support it.

Puberty Blockers, Cross-Sex Hormones, and Youth Suicide

Lowering legal barriers to make it easier for minors to undergo cross-sex medical interventions without parental consent does not reduce suicide rates—in fact, it likely leads to higher rates of suicide among young people in states that adopt these changes. States should instead adopt parental bills of rights that affirm the fact that parents have primary responsibility for their children’s education and health, and that require school officials and health professionals to receive permission from parents before administering health services, including medication and “gender-affirming” counseling, to children under 18. States should also tighten the criteria for receiving cross-sex treatments, including raising the minimum eligibility age.

Letter to the Editor: “Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline”

There are no laboratory, imaging, or other objective tests to diagnose a “true transgender” child. Children with GD will outgrow this condition in 61% to 98% of cases by adulthood. There is currently no way to predict who will desist and who will remain dysphoric. The degree to which GAT has contributed to the rapidly increasing prevalence of GD in children is unknown. The recent phenomenon of teenage girls suddenly developing GD (rapid onset GD) without prior history through social contagion is particularly concerning .

Aricles

Podcasts

Other Resources

Ruling in THE TAVISTOCK AND PORTMAN NHS FOUNDATION TRUST case UK

This is a claim for judicial review of the practice of the defendant, the Tavistock and Portman NHS Foundation Trust, through its Gender Identity Development Service (GIDS) and the first and second Interveners (the Trusts) of prescribing puberty-suppressing drugs to persons under the age of 18 who experience gender dysphoria.